|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
106.75(B) |
Last
Volume: |
6,978,222 |
Avg
Vol: |
8,439,653 |
52
Week Range: |
$48.64 - $74.55 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
131,028 |
294,034 |
784,747 |
1,896,260 |
Total Sell Value |
$9,081,880 |
$18,529,068 |
$44,400,077 |
$93,901,157 |
Total People Sold |
8 |
9 |
11 |
13 |
Total Sell Transactions |
13 |
22 |
38 |
73 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sorenson John Bradley |
EVP, Global Operations |
|
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,202 |
41,249 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-01-01 |
4 |
D |
$46.27 |
$1,044,592 |
D/D |
(22,576) |
1,802,880 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,791 |
1,825,456 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2023-01-01 |
4 |
D |
$46.27 |
$187,023 |
D/D |
(4,042) |
273,382 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,134 |
277,424 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-01-01 |
4 |
D |
$46.27 |
$149,452 |
D/D |
(3,230) |
95,230 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,981 |
98,460 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-01-01 |
4 |
D |
$46.27 |
$180,638 |
D/D |
(3,904) |
35,358 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,405 |
39,262 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-01-01 |
4 |
D |
$46.27 |
$143,437 |
D/D |
(3,100) |
90,880 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,567 |
93,980 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-01-01 |
4 |
D |
$46.27 |
$308,066 |
D/D |
(6,658) |
223,347 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,134 |
230,005 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2022-12-15 |
4 |
AS |
$46.62 |
$349,668 |
D/D |
(7,500) |
87,413 |
|
12% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2022-12-13 |
4 |
AS |
$47.78 |
$3,787,234 |
D/D |
(79,264) |
216,871 |
|
8% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2022-12-13 |
4 |
OE |
$7.39 |
$585,761 |
D/D |
79,264 |
296,135 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-12-12 |
4 |
AS |
$46.75 |
$517,990 |
D/D |
(11,080) |
88,479 |
|
9% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-12-09 |
4 |
AS |
$46.15 |
$1,893,504 |
D/D |
(41,032) |
99,559 |
|
11% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-12-09 |
4 |
OE |
$13.08 |
$387,155 |
D/D |
29,599 |
140,591 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-12-03 |
4 |
D |
$46.60 |
$13,794 |
D/D |
(296) |
110,992 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
649 |
111,288 |
|
- |
|
Connors Nelda J |
Director |
|
2022-11-29 |
4 |
S |
$44.47 |
$809,243 |
I/I |
(18,196) |
27,246 |
|
-14% |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2022-11-18 |
4 |
S |
$42.72 |
$638,773 |
D/D |
(14,952) |
57,534 |
|
-16% |
|
Carruthers Wendy |
EVP, Human Resources |
|
2022-11-15 |
4 |
AS |
$42.60 |
$71,483 |
D/D |
(1,678) |
94,913 |
|
16% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2022-11-07 |
4 |
AS |
$41.97 |
$5,280,997 |
D/D |
(125,827) |
1,767,665 |
|
16% |
|
4527 Records found
|
|
Page 15 of 182 |
|
|